当前位置: 首页 » 政策法规 » 国外法规 »(EU) 2015/1078:就药理学活性物质氯膦酸(二钠盐的形式),修订(EU) No 37/2010号法规(amending Regulation (EU) No 37/2010 as regards the substance ‘clodronic acid (in the form of disodium salt))

(EU) 2015/1078:就药理学活性物质氯膦酸(二钠盐的形式),修订(EU) No 37/2010号法规(amending Regulation (EU) No 37/2010 as regards the substance ‘clodronic acid (in the form of disodium salt))

扫描二维码 分享好友和朋友圈
放大字体  缩小字体 2015-07-06 09:24:19  来源:欧盟  浏览次数:2947
核心提示:2015年7月4日,欧盟发布委员会实施条例(EU) 2015/1078,对(EU) No 37/2010进行修正。在附录表1中增加氯膦酸二钠盐在马科物种中的的残留限量规定,规定在马科物种中不允许有氯膦酸二钠盐的存在。
发布单位
欧盟委员会
欧盟委员会
发布文号 (EU) 2015/1078
发布日期 2015-07-04 生效日期 2015-07-24
有效性状态 废止日期 暂无
备注 2015年7月4日,欧盟发布委员会实施条例(EU) 2015/1078,对(EU) No 37/2010进行修正。在附录表1中增加氯膦酸二钠盐在马科物种中的的残留限量规定,规定在马科物种中不允许有氯膦酸二钠盐的存在。所有用于食品生产的动物物种中不允许有氯膦酸二钠盐的存在。
  THE EUROPEAN COMMISSION,
 
  Having regard to the Treaty on the Functioning of the European Union,
 
  Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (1), and in particular Article 14 in conjunction with Article 17 thereof,
 
  Having regard to the opinion of the European Medicines Agency formulated by the Committee for Medicinal Products for Veterinary Use,
 
  Whereas:
 
  (1)
 
  Article 17 of Regulation (EC) No 470/2009 requires that the maximum residue limit (hereinafter ‘MRL’) for pharmacologically active substances intended for use in the Union in veterinary medicinal products for food-producing animals or in biocidal products used in animal husbandry is to be established in a regulation.
 
  (2)
 
  Table 1 of the Annex to Commission Regulation (EU) No 37/2010 (2) sets out the pharmacologically active substances and their classification regarding MRLs in foodstuffs of animal origin.
 
  (3)
 
  Clodronic acid (in the form of disodium salt) is not yet included in this table.
 
  (4)
 
  An application for the establishment of MRLs for clodronic acid (in the form of disodium salt) in equidae has been submitted to the European Medicines Agency (hereinafter ‘EMA’).
 
  (5)
 
  The EMA, based on the opinion of the Committee for Medicinal Products for Veterinary Use, has recommended that the establishment of maximum residue limits for clodronate disodium in equine species is not necessary for the protection of human health, provided that the substance is not used for animals producing milk for human consumption.
 
  (6)
 
  According to Article 5 of Regulation (EC) No 470/2009, the EMA is to consider using MRLs established for a pharmacologically active substance in a particular foodstuff for another foodstuff derived from the same species, or MRLs established for a pharmacologically active substance in one or more species for other species.
 
  (7)
 
  The EMA has considered that the extrapolation of the MRL for clodronic acid (in the form of disodium salt) for equidae to other food producing species is not appropriate, because based on the proposed indication and mode of action, it is not likely that this active substance would be used in any food species other than horses.
 
  (8)
 
  Table 1 of the Annex to Regulation (EU) No 37/2010 should therefore be amended accordingly.
 
  (9)
 
  The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
 
  HAS ADOPTED THIS REGULATION:
 
  Article 1
 
  The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
 
  Article 2
 
  This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
 
  It shall apply from 2 September 2015.
 
  This Regulation shall be binding in its entirety and directly applicable in all Member States.
 
  Done at Brussels, 3 July 2015.
 
  For the Commission
 
  The President
 
  Jean-Claude JUNCKER
 
  (1)  OJ L 152, 16.6.2009, p. 11.
 
  (2)  Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010, p. 1).
ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, the following substance is inserted in alphabetical order:

Pharmacologically active Substance

Marker residue

Animal Species

MRL

Target Tissues

Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic classification

‘Clodronic acid (in the form of disodium salt)

NOT APPLICABLE

Equidae

No MRL required

NOT APPLICABLE

Not for use in animals from which milk is produced for human consumption

Musculoskeletal system/drugs for treatment of bone diseases’

 地区: 欧盟 
 标签: 活性物质 残留限量 
食品伙伴网提供标准法规解读、舆情监控、合规咨询、申报注册等服务。
电询:0535-2129301
QQ:2891238009
食品标法圈
实时把握食品标法动态
请扫码关注食品标法圈

声明:

① 凡本网所有原始/编译文章及图片、图表的版权均属食品伙伴网所有,如要转载,需注明“信息来源:食品伙伴网”。
② 凡本网注明“信息来源:XXX(非食品伙伴网)”的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责。
※ 邮箱:law#foodmate.net(发邮件时请将#换成@) QQ:139307733

 
 
[ 政策法规搜索 ]  [ 加入收藏 ]  [ 告诉好友 ]  [ 打印本文 [ 关闭窗口 ]

 

 
 
按分类浏览
国家法规 (12118) 国外法规 (3603)
地方法规 (42072) 法规动态 (12)
法规解读 (2939) 其他法规 (344)
推荐国外法规
点击排行
    按国家或地区浏览

    法规中心  关于我们  广告业务  联系我们  信息服务

    Processed in 0.507 second(s), 12 queries, Memory 4.5 M